Literature DB >> 11740911

1,2-diacetylbenzene, the neurotoxic metabolite of a chromogenic aromatic solvent, induces proximal axonopathy.

M S Kim1, M I Sabri, V H Miller, R J Kayton, D A Dixon, P S Spencer.   

Abstract

Several widely used aromatic hydrocarbon solvents reportedly induce blue-green discoloration of tissues and urine in animals and humans. The chomophore has been proposed to result from a ninhydrin-like reaction with amino groups in proteins. The present study examines the neurotoxic property of 1,2-diacetylbenzene (1,2-DAB), the active metabolite of the chromogenic and neurotoxic aromatic solvent 1,2-diethylbenzene. Rats treated with 1,2-DAB, but not with the nonchromogenic isomer 1,3-DAB or with ninhydrin developed blue discoloration of internal organs, including the brain and spinal cord. Only 1,2-DAB induced limb weakness associated with nerve fiber changes, which were most prominent in spinal cord and spinal roots. Changes began with the formation of proximal, neurofilament-filled axonal swellings of the type seen after treatment with 3,4-dimethyl-2,5-hexanedione, a potent derivative of the active metabolite of the neurotoxic aliphatic hydrocarbon solvents n-hexane and methyl n-butyl ketone. These compounds are metabolized to a gamma-diketone that forms pyrroles with target proteins, such as neurofilament proteins. A comparable mechanism is considered for 1,2-DAB, an aromatic gamma-diketone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11740911     DOI: 10.1006/taap.2001.9301

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

1.  Monocyclic and dicyclic hydrocarbons: structural requirements for proximal giant axonopathy.

Authors:  Desire D Tshala-Katumbay; Valerie S Palmer; Michael R Lasarev; Robert J Kayton; Mohammad I Sabri; Peter S Spencer
Journal:  Acta Neuropathol       Date:  2006-07-28       Impact factor: 17.088

2.  Proximal giant neurofilamentous axonopathy in mice genetically engineered to resist calpain and caspase cleavage of α-II spectrin.

Authors:  R Kassa; V Monterroso; J Wentzell; A L Ramos; E Couchi; M C Lecomte; M Iordanov; D Kretzschmar; G Nicolas; D Tshala-Katumbay
Journal:  J Mol Neurosci       Date:  2012-01-03       Impact factor: 3.444

Review 3.  Neuroprotein Targets of γ-Diketone Metabolites of Aliphatic and Aromatic Solvents That Induce Central-Peripheral Axonopathy.

Authors:  Peter S Spencer
Journal:  Toxicol Pathol       Date:  2020-03-12       Impact factor: 1.902

Review 4.  Toxic Peripheral Neuropathies: Agents and Mechanisms.

Authors:  William M Valentine
Journal:  Toxicol Pathol       Date:  2019-06-10       Impact factor: 1.902

5.  Therapeutic effect of the combined use of growth hormone releasing peptide-6 and epidermal growth factor in an axonopathy model.

Authors:  Diana García Del Barco; Héctor Pérez-Saad; Valia Rodríguez; Javier Marín; Viviana Falcón; Jorge Martín; Danay Cibrian; Jorge Berlanga
Journal:  Neurotox Res       Date:  2010-02-19       Impact factor: 3.911

6.  Probing mechanisms of axonopathy. Part II: Protein targets of 2,5-hexanedione, the neurotoxic metabolite of the aliphatic solvent n-hexane.

Authors:  Desire Tshala-Katumbay; Victor Monterroso; Robert Kayton; Michael Lasarev; Mohammad Sabri; Peter Spencer
Journal:  Toxicol Sci       Date:  2008-11-25       Impact factor: 4.849

Review 7.  The Role of Protein Adduction in Toxic Neuropathies of Exogenous and Endogenous Origin.

Authors:  Peter S Spencer; Xiao Chen
Journal:  Toxics       Date:  2021-04-29

8.  Protein pyrrole adducts are associated with elevated glucose indices and clinical features of diabetic diffuse neuropathies.

Authors:  Xiao Chen; Zhuyi Jiang; Lianjing Zhang; Wei Liu; Xiaohu Ren; Luling Nie; Desheng Wu; Zhiwei Guo; Weimin Liu; Xifei Yang; Yan Wu; Zhen Liang; Peter Spencer; Jianjun Liu
Journal:  J Diabetes       Date:  2022-10-04       Impact factor: 4.530

9.  Axonopathy-inducing 1,2-diacetylbenzene forms adducts with motor and cytoskeletal proteins required for axonal transport.

Authors:  Mohammad I Sabri; Seyed B Hashemi; Michael R Lasarev; Peter S Spencer
Journal:  Neurochem Res       Date:  2007-06-19       Impact factor: 4.414

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.